Booster Vaccination With Pneumococcal Vaccine GSK1024850A or Prevenar™ Co-administered With Hiberix™ in Children Primed With the Same Vaccines

Trial Profile

Booster Vaccination With Pneumococcal Vaccine GSK1024850A or Prevenar™ Co-administered With Hiberix™ in Children Primed With the Same Vaccines

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Nov 2016

At a glance

  • Drugs Pneumococcal vaccine (Primary) ; Hib vaccine conjugate
  • Indications Influenza B virus infections; Otitis media; Pneumococcal infections
  • Focus Adverse reactions; Registrational
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 13 Jan 2012 Actual end date changed from Jan 2010 to May 2009 as reported by ClinicalTrials.gov.
    • 13 Jan 2012 Actual initiation date changed from Jun 2009 to Jun 2008 as reported by ClinicalTrials.gov.
    • 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (NCT00680914).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top